Needham reiterated coverage on Generation Bio with a new price target

12/15/21 6:40:48 AM ET

Biotechnology: Pharmaceutical Preparations

Health Care

Needham reiterated coverage of Generation Bio with a rating of Buy and set a new price target of $27.00 from $50.00 previously

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$GBIO

Date	Price Target	Rating	Analyst
10/19/2023		Outperform → Market Perform	TD Cowen
11/8/2022	$9.00	Buy	Canaccord Genuity
12/15/2021	$40.00 → $10.00	Market Outperform	JMP Securities
12/15/2021	$50.00 → $27.00	Buy	Needham
12/14/2021		Outperform → Mkt Perform	William Blair